T-type calcium channel blocker
US-2022363667-A1 · Nov 17, 2022 · US
Small molecule modulators of PanK
US12534451B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12534451-B2 |
| Application number | US-202017598163-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 26, 2020 |
| Priority date | Mar 27, 2019 |
| Publication date | Jan 27, 2026 |
| Grant date | Jan 27, 2026 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure relates to chemical compounds that modulate pantothenate kinase (PanK) activity for the treatment of metabolic disorders (such as diabetes mellitus type II), neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment.
First claim
Opening claim text (preview).
What is claimed is: 1 . A compound selected from the group consisting of: 2 . A pharmaceutical composition comprising a therapeutically effective amount of at least one compound of claim 1 and a pharmaceutically acceptable carrier. 3 . The compound of claim 1 , wherein the compound is selected from the group consisting of: 4 . The compound of claim 1 , wherein the compound is: 5 . The compound of claim 1 , wherein the compound is selected from the group consisting of: 6 . The compound of claim 1 , wherein the compound is selected from the group consisting of: 7 . The compound of claim 1 , wherein the compound is selected from the group consisting of: 8 . The compound of claim 1 , wherein the compound is selected from the group consisting of: 9 . The compound of claim 1 , wherein the compound is selected from the group consisting of: 10 . The compound of claim 1 , wherein the compound is: 11 . The compound of claim 1 , wherein the compound is: 12 . The compound of claim 1 , wherein the compound is: 13 . The compound of claim 1 , wherein the compound is: 14 . The compound of claim 1 , wherein the compound is: 15 . The compound of claim 1 , wherein the compound is: 16 . The compound of claim 1 , wherein the compound is: 17 . The compound of claim 1 , wherein the compound is: 18 . The compound of claim 1 , wherein the compound is:
Assignees
Inventors
Classifications
Ortho-condensed systems · CPC title
Ortho-condensed systems · CPC title
Ortho-condensed systems · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12534451B2 cover?
- The present disclosure relates to chemical compounds that modulate pantothenate kinase (PanK) activity for the treatment of metabolic disorders (such as diabetes mellitus type II), neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment.
- Who is the assignee on this patent?
- St Jude Childrens Res Hospital, St Jude Childrens Res Hospital Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D403/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).